The majority of these confirmed CDA‐I with mutations in CDAN1 or C15orf41, but 20% had an alternative diagnosis, such as DBA with an unusual marrow in early childhood, and PK deficiency (Roy et al, 2016). This evidence concerns the gene CDAN1 and pyruvate kinase deficiency of red cells.